PHYTOTHERAPY: CURRENT ASPECTS

Download full text PDF
DOI: https://doi.org/None
Issue: 
6
Year: 
2016

A.V. Shchulkin, MD; I.V. Chernykh, PhD; N.M. Popova, MD; E.N. Yakusheva, MD Acad. I.P. Pavlov Ryazan State Medical University; 9, Vysokovoltnaya St., Ryazan 390026, Russian Federation

The paper considers the legal aspects of preclinical studies of the specific activity of drugs of natural origin and their toxicological studies in the Russian Federation, as well as the U.S. Food and Drug Administration guidelines for the registration of herbal medicines. It characterizes rules for registering dietary supplements in the Russian Federation. The problems of drug-drug interaction involving herbal agents and those of standardization of drugs of natural origin on the pharmaceutical market of the Russian Federation are given.
Keywords: 
phytotherapy
medicinal plant drug
registration of herbal medicines
study of the specific activity of herbal medicines
toxicological studies of herbal medicines
dietary supplements
References: 
  1. Leclerc H. Precis de phytotherapie; essais de thirapeutique par les plantes frangaises. Paris: Masson, 1999; 363.
  2. Du Y., Wolf I.K., Zhuang W., Bodemann S., Knoss W., Knopf H. Use of herbal medicinal product samong children and adoles centsin Germany. BMC Complement. Altern. Med. 2014; 14: 218.
  3. Federal`nyy zakon № 429-FZ ot 22.12.2014 (red. ot 13.07.2015) «O vnesenii izmeneniy v Federal`nyy zakon «Ob obrashhenii lekarstvennyh sredstv» [The federall aw of 22.12.2014 № 429-FZ (an edition of 13.07.2015) «About modification of the Federal law «About using of the drugs» (in Russian)].
  4. Federal`nyy zakon № 29-FZ ot 02.01.2000 (red. ot 13.07.2015) «O kachestve i bezopasnosti pishhevyh produktov» [The federal law of 02.01.2000 № 29-FZ (an edition of 13.07.2015) «About quality and safety of foodstuff» (in Russian)].
  5. De Smet P.A. Health risks of herbal remedies. Drug Saf. 1995; 13: 81–93. 6. U.S. Food and Drug Administration, Center for Drug Evaluation. Guidance for industry: drug interaction study design, data analysis, implications for dosing, and labeling recommendations.
  6. Rukovodstvo po provedeniyu doklinicheskih issledovaniy lekarstvennyh sredstv (pod red. A.N. Mironova). Ch. 1. M.: GrifiK, 2012; 944 [The guide about preclinical researches of the drugs (ed A.N. Mironov). r.1.Moscow, 2012; 944 (in Russian)].
  7. Durnev A.D., Lapickaya A.S. Genotoksikologiya soedineniy rastitel`nogo proishozhdeniya. Geneticheskaya toksikologiya i geneticheski aktivnye faktory sredy, 2012; 10. 3: 41–52 [Durnev A.D., Lapitskaya A.S. Genotoxicology of plant compounds. Genetic toxicology and genetically active factors of environment, 2012; 10. 3: 41–52 (in Russian)].
  8. Prikaz Ministerstva zdravoohraneniya i social`nogo razvitiya RF № 657 ot 19.10.2007 «Ob utverzhdenii administrativnogo reglmenta Federal`noy sluzhby po nadzoru v sfere zashhity prav potrebiteley i blagopoluchiya cheloveka po ispolneniyu gosudarstvennoy funkcii po gosudarstvennoy registracii vpervye vnedryaemyh v proizvodstvo i ranee ne ispol`zovavshihsya himicheskih, biologicheskih veshhestv i izgotavlivaemyh na ih osnove preparatov, potencial`no opasnyh dlya cheloveka (krome lekarstvennyh sredstv); otdel`nyh vidov produkcii, predstavlyayushhih potencial`nuyu opasnost` dlya cheloveka (krome lekarstvennyh sredstv); otdel`nyh vidov produkcii, v tom chisle pishhevyh produktov, vpervye vvozimyh na territoriyu Rossiyskoy Federacii» [The order of the Ministry of Health and Social Development of Russian Federation of 19.10.2007 № 657 «About the approval of Administrative regulations of Federal services on supervision in the sphere of protection of the rights of consumers and wellbeing of the person on execution state functions on state registration for the first time introduced in production and earlier not used chemical, biological substances and the preparations potentially
  9. dangerous to the person made on their basis (except drugs); the separate types of production constituting potential danger to the person (except drugs); separate types of production, including the foodstuff for the first time imported on the territory of Russian Federation» (in Russian)].
  10. Hotimchenko Yu.S. Biologicheski aktivnye dobavki k pishhe: zakonodatel`naya baza i primenenie v medicine. Tihookeanskiy medicinskiy zhurnal, 2006; 3: 19–22. [Hotimchenko Yu.S. Biologically active additives in food: legislative base and application in medicine. Tikhookeansky medical journal, 2006; 3: 19–22 (in Russian)].
  11. Mishina E. Vot BADy. Rossiyskaya gazeta, 1 5987 (22 yanv.): 3. [Mishina E. Biologically active additives in food. Rossiisky newspaper, 1 5987 (22 January): 3 (in Russian)].
  12. Sychev D.A., Shih E.V., Bulaev V.M., Ramenskaya G.V., Kukes V.G., Kolhir S.V. Mehanizmy farmakokineticheskogo vozdeystviya lekarstvennyh sredstv i fitopreparatov: vzglyad klinicheskogo farmakologa. Biomedicina, 2005; 1: 25–34. [Sychev D.A. , Shih E.V., Bulaev V.M., Ramenskaya G.V., Kukes V.G., Kolhir S.V. Pharmacokinetical interaction of drugs and herbal preparations. Biomedicine, 2005; 1: 25–34 (in Russian)].
  13. Yakusheva E.N., Chernyh I.V., Shhul`kin A.V., Gacanoga M.V. Metodika opredeleniya prinadlezhnosti lekarstvennyh sredstv k chislu substratov glikoproteina-P. Rossiyskiy mediko-biologicheskiy vestnik im. akad. I.P. Pavlova, 2015; 3: 49–53. [Yakusheva E.N., Chernykh I.V., Shchulkin A.V., Gatsanoga M.V. Methods of identification of drugs as P-glycoprotein substrates. Rossiyskiy mediko-biologicheskiy vestnik imeni akademika I.P. Pavlova, 2015; 3: 49–53 (in Russian)].
  14. Titov D.S., Pravkin S.K. Izuchenie haraktera i prodolzhitel`nosti vliyaniya proizvodnogo sul`fonilmocheviny II pokoleniya – glikvidona na funkcional`nuyu aktivnost` lekarstvennogo transportera glikoproteina-R. Nauka molodyh (Eruditio Juvenium), 2016; 1: 98–103. [Titov D.S., Pravkin S.K. The study of the nature and duration of effect derived sulfonylureas II generation glikvidona on the functional activity of drug Transporter glycoprotein-R. Nauka molodykh (Eruditio Juvenium), 2016; 1: 98–103 (in Russian)].
  15. Zhigunova A.K. Primenenie uroantiseptikov pri lechenii zabolevaniy mochevydelitel`noy sistemy v period beremennosti. UKR. MED. ChASOPIS, 2013; 1 (93). I/II: 103–109 [Zhigunova A.K. Using of uroantiseptics at treatment of system diseases during pregnancy. UKR.MEDICAL CHASOPIS, 2013; 1 (93). I/II: 103-109 (in Russian)].